Real-world efficacy of letermovir prophylaxis for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: A single-center retrospective analysis-Reference-Cited by-同舟云学术

Real-world efficacy of letermovir prophylaxis for cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation: A single-center retrospective analysis

Published:2022-09 Issue:9 Volume:28 Page:1317-1323
ISSN:1341-321X
Container-title:Journal of Infection and Chemotherapy
language:en
Short-container-title:Journal of Infection and Chemotherapy

Author:

Yoshimura Hideaki,Satake Atsushi^ORCID,Ishii Yuka,Ichikawa Jun,Saito Ryo,Konishi Akiko,Hotta Masaaki,Nakanishi Takahisa,Fujita Shinya,Ito Tomoki,Ishii Kazuyoshi,Nomura Shosaku

Funder

Department of Internal Medicine, University of Utah

Kansai Medical University

Publisher

Elsevier BV

Subject

Infectious Diseases,Pharmacology (medical),Microbiology (medical)

Reference41 articles.

1. Antiviral prophylaxis for cytomegalovirus infection in allogeneic hematopoietic cell transplantation;Chen;Blood Adv,2018

2. Cytomegalovirus pp65 antigenemia-guided early treatment with ganciclovir versus ganciclovir at engraftment after allogeneic marrow transplantation: a randomized double-blind study;Boeckh;Blood,1996

3. How we treat cytomegalovirus in hematopoietic cell transplant recipients;Boeckh;Blood,2009

4. CMV in Hematopoietic stem cell transplantation;de la Cámara;Mediterr J Hematol Infect Dis,2016

5. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Real-world experience with letermovir for cytomegalovirus-prophylaxis after allogeneic hematopoietic cell transplantation: A multi-centre observational study;Journal of Infection;2024-08

2. Real-World Safety and Effectiveness of Letermovir in Patients Undergoing Allogenic Hematopoietic Stem Cell Transplantation: Final Results of Post-Marketing Surveillance in Japan;Clinical Drug Investigation;2024-06-27

3. Approaches and Challenges in the Current Management of Cytomegalovirus in Transplant Recipients: Highlighting the Role of Advanced Practice Providers (Nurse Practitioners and Physician Assistants);Annals of Transplantation;2024-03-15

4. Letermovir for cytomegalovirus infection in allogeneic hematopoietic stem-cell transplantation: tips and notes for effective use in clinical practice;Expert Review of Anti-infective Therapy;2024-03

5. Efficacy and safety of letermovir prophylaxis for cytomegalovirus infection after hematopoietic stem cell transplantation;Blood Science;2024-01